Educational guide
BIM BH3 apoptosis-inducing peptide for cancer research
BIM BH3 - apoptosis-inducing peptide US$392.60 Excluding tax and shipping fees In stock Description About BIM BH3 - apoptosis-inducing peptide BIM BH3 is an apoptosis-inducing peptide for cancer research. The BIM BH3 peptide, H-MRPEIWIAQELRRIGDEFNA-OH from JPT
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
BIM BH3 - apoptosis-inducing peptide
US$392.60
Excluding tax and shipping fees
In stock
Description
About BIM BH3 - apoptosis-inducing peptide
BIM BH3 is an apoptosis-inducing peptide for cancer research. The BIM BH3 peptide, H-MRPEIWIAQELRRIGDEFNA-OH from JPT is produced under strict quality control and quality management.
BIM BH3 apoptosis-inducing peptide - Specifications
Peptide sequence: H-MRPEIWIAQELRRIGDEFNA-OH2
Amount: 5 mg
Purity: > 95% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Non-RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s Non-RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for BIM BH3 - apoptosis-inducing peptide
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for BIM BH3 - apoptosis-inducing peptide
BIM-BH3-apoptosis-inducing-peptide.pdf
Properties
Properties of BIM BH3 - apoptosis-inducing peptide
5 mg
T-cell immunity
Cancer peptides, Cancer peptides Non-RGD
Cancer
Freeze-dried in plastic vial
Human
Bcl-2-related protein
>95% (HPLC-MS)
No
Further Information to BIM BH3 - apoptosis-inducing peptide
Values
H-MRPEIWIAQELRRIGDEFNA-OH
Related Products
Related Products
Bak BH3
US$220.05
iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0
US$177.67
Proapoptotic Peptide KLA
US$326.22
RGD-4C, CAS 332179-76-7
US$282.50
PAR-4 agonist peptide, CAS 352017-71-1
US$514.80
GRGD-acid, CAS 97461-81-9
Cecropin A Peptide
US$381.12
T3 Peptide,Tumstatin (69-88), human
US$853.11
Azurin p28 peptide, CAS 897026-25-4
US$334.90